论文部分内容阅读
目的探讨骨质疏松伴椎动脉型颈椎病临床治疗方法。方法将收治的60例伴骨质疏松的椎动脉型颈椎病患者,依据治疗方法分为治疗组和对照组各30例,治疗组采用静脉输注复方骨肽注射液+长春西汀注射液,对照组采用静脉输注盐酸丁咯地尔注射液,比较两组治疗效果。结果治疗后,治疗组总有效率为96.67%,对照组总有效率为86.67%,治疗组明显优于对照组;两组患者的基底动脉与双椎动脉的Vs、Vd、PI、RI四项均得到明显改善,与治疗前相比均有显著性差异(P<0.01);与对照组比较,治疗组在基底动脉与双椎动脉的Vs、Vd、PI、RI四项有显著性差异(P<0.05),明显高于对照组。结论复方骨肽注射液联合长春西汀注射液治疗本病可显著提高愈显率,提高椎-基底动脉的血流速度,增加血管弹性,降低血管阻力,值得临床推广应用。
Objective To investigate the clinical treatment of osteoporosis with vertebral artery type cervical spondylosis. Methods Sixty patients with vertebral artery-type cervical spondylosis who were treated with osteoporosis were divided into treatment group (n = 30) and control group (n = 30). The treatment group received intravenous injection of compound osteopeptide injection and vinpocetine injection, In the control group, buflomedil hydrochloride was injected intravenously to compare the therapeutic effect of the two groups. Results After treatment, the total effective rate was 96.67% in the treatment group and 86.67% in the control group, which was obviously superior to the control group. Vs, Vd, PI and RI of the basilar artery and the bilateral vertebral artery (P <0.01). Compared with the control group, there were significant differences of Vs, Vd, PI and RI in the basilar artery and the bilateral vertebral artery P <0.05), significantly higher than the control group. Conclusions The compound osteopeptide injection combined with vinpocetine injection in the treatment of this disease can significantly improve the curettage rate, increase the vertebrobasilar artery blood flow velocity, increase the blood vessel elasticity and reduce the vascular resistance, which is worthy of clinical application.